Abstract
Although sulfatide (galactosylceramide I3-sulfate) has been reported to activate blood coagulation factor XII (Hageman factor), it has been administered to animals without subsequent thrombus formation. We recently found that sulfatide binds to fibrinogen and thus disturbs fibrin formation in vitro, suggesting its possible role as an anticoagulant rather than as a coagulant. We therefore examined the in vivo effects of sulfatide on thrombogenesis by using a rat deep vein thrombosis model in which thrombus is induced by ligating the inferior vena cava. Sulfatide and gangliosides were each separately administered to rats 1 min before the vein ligation, and after 3 h, sulfatide but not gangliosides markedly (P < .001) enhanced the thrombogenesis. A kinetic turbidmetric assay of plasma coagulation initiated by CaCl2 in the wells of a microtiter plate revealed that coagulation was also markedly accelerated in the presence of sulfatide but not gangliosides, the results of which seemed to be very consistent with those of the in vivo experiments. Because sulfatide could not induce thrombosis without vein ligation in rats, the enhancement of thrombogenesis by sulfatide in the in vivo model might require endothelial damage and/or venous congestion, both of which could be induced by vein ligation.
Similar content being viewed by others
References
Yamakawa T, Kiso N, Handa S, Makita A, Yokoyama J (1962) J Biochem 52: 226–7.
Wago K (1961) Jpn Hear J 2: 354–67.
Fujikawa K, Heimark RL, Kurachi K, Davie EW (1980) Biochemistry 19: 1322–30.
Tans G, Griffin JH (1982) Blood 59: 69–75.
Saito H (1994) In Haemostasis and Thrombosis, 3rd edition (Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, eds) pp 289–307. Edinburgh: Churchill Livingstone.
Mann KG, Jenny RJ, Krishnaswamy S (1988) Ann Rev Biochem 57: 915–56.
Schmaier AH (1997) Thromb Haemost 78: 101–7.
Taketomi T, Hara A, Uemura K, Kyogashima, N (1989) Jpn J Exp Med 59: 221–31.
Zhu X, Hara A, Taketomi T (1991) J Biochem 110: 241–5.
Hara A, Uemura K, Taketomi T (1996) Glycoconjugate J 13: 187–94.
Hara A, Taketomi T (1987) J Biochem 102: 83–92.
Hara A, Taketomi T (1991) J Biochem 109: 904–8.
Reyer I, Mussoni L, Donati MD, Gaetano, GD, (1980) Thromb Res 18: 669–74.
Tanaka S, Iwanaga S (1993) Methods Enzymol 223: 358–64.
Bianchini P, Osima B, Parma B, Nader HB, Dietrich CP (1985) Thromb Res 40: 597–607.
Ganong WF(1995) In Review of Medical Physiology, 17th edition. Norwalk: Appleton & Lange.
Broze Jr GJ (1994) In Haemostasis and Thrombosis, 3rd edition (Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, eds) pp 349–77. Edinburgh: Churchill Livingstone.
Poller L, Thomson JM (1993) In Recent Advances in Blood Coagulation 6 (Poller L, ed) pp 155–68. Edinburgh: Churchill Livingstone.
Edwards RL, Rickles, FR (1993) In Role of Procoagulant Activity in Health and Disease (Levy GA, Cole EH, eds) pp 153–76. Boca Raton: CRC Press Inc.
Sakakibara N, Gasa K, Kamio K, Makita A, Koyanagi T (1989) Cancer Res 49: 335–39.
Aruffo A, Kolanus W, Walz G, Fredman P, Seed B(1991) Cell 67: 35–44.
Aicardi J (1993) J Inher Metab Dis 16: 733–43.
Krivit W, Lockman LA, Watkins PA, Hirsch J, Shapiro EG (1995) J Inher Metab Dis 18: 398–412.
Holdsworth S, Tipping P (1993) in Role of Procoagulant Activity in Health and Disease (Levy GA, Cole EH, eds) pp 131–51. Boca Raton: CRC Press Inc.
Farquhar A, MacDonald MK, Ireland, AJ (1972) J Clin Path 25: 657–67.
Buschard K, Josefsen K, Horn T, Larsen S, Fredman P (1993) APMIS 101: 963–70.
Ofosu FA (1993) In Recent Advances in Blood Coagulation 6 (Poller L, ed.) pp 51–68. Edinburgh: Churchill Livingstone.
Roberts DD, Ginsburg V (1988) Arch Biochem Biophys 267: 405–15.
Roberts DD, Rao CN, Magnani JL, Spitalnik SL, Liotta LA, Ginsburg V (1985) Proc Natl Acad Sci U S A 82: 1306–10.
Roberts DD, Haverstick DM, Dixit VM, Frazier WA, Santoro SA, Ginsburg V (1985) J Biol Chem 260: 9405–11.
Roberts DD, Williams SB, Gralnick HR, Ginsburg V (1986) J Biol Chem 261: 3306–09.
Holt GD, Krivan HC, Gasic GJ, Ginsburg V (1989) J Biol Chem 264: 12138–40.
Holt GD, Pangburn MK, Ginsburg V (1990) J Biol Chem 265: 2852–55.
Suzuki Y, Toda Y, Tamatani T, Kiso M, Hasegawa A, Tadano-Aritomi K, Ishizuka I, Miyasaka M (1993) Biochem Biophys Res Comm 190: 426–34.
Higashi H, Suzuki Y, Mukaida N, Takahashi N, Miyamoto D, Matsushima K (1997) Infect Immun 65: 1223–7.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kyogashima, M., Onaya, J., Hara, A. et al. Sulfatide can markedly enhance thrombogenesis in rat deep vein thrombosis model. Glycoconj J 15, 915–922 (1998). https://doi.org/10.1023/A:1006967217828
Issue Date:
DOI: https://doi.org/10.1023/A:1006967217828